Clinical Cell Therapy Leadership Micro Course

ABOUT THE COURSE

Developed by world-renowned leaders in Cell and Gene Therapy (CGT) directing the biennial ISCT Cell Therapy Leadership Training Program, the Cell Therapy Leadership training micro-course is an 10-hour on-demand course designed for Principal Investigators, Clinical Development Scientists, and Industry professionals involved in translational research, product development, and clinical trial sponsorship.

You will learn how to effectively navigate the complexities of bringing CGT products from bench to bedside, with comprehensive insights into critical areas such as IND submissions, clinical trial design, GMP standards, Quality Assurance, Technology Licensing, and patient access. 

What you will learn
  • Key considerations for translating research to clinical manufacturing
  • Key insights for effective IND submissions
  • Analytical approaches to study design, product safety and release criteria to support clinical decision-making and regulatory approval
  • Correlative studies in assessing gene transfer, immunogenicity, and toxicity 
  • Strategic implementation of GMP standards in cell and gene therapy manufacturing
  • Insights into optimizing viral vector production and release testing
  • Leading effective cell therapy teams
  • Regulatory insights for establishing robust quality systems in early product development for meeting regulatory requirements
  • CAR-T and gene therapies cost structure
  • Academia-to-industry partnerships, IP production, and commercialization pathways

PRICE (USD)
IISCT Members INon-Members
Academia $500 $1230
Industry $930

Did you know you can become an ISCT member for as little as $55/year? Learn more about ISCT membership benefits here.

For full details on our course policies, including cancellations, complaints and appeals processes and our privacy policy, click here.

Self-paced virtual course
10-hour training

Register now

DESIGNED FOR:

This micro-course is specifically tailored for professionals involved in Cell and Gene Therapy (CGT) and Bone Marrow Transplantation (BMT), focusing on product development, clinical research, and commercialization. The program is ideal for: 

  • Clinical Development Scientists: Professionals managing the transition from research to clinical application. 
  • Principal Investigators: Researchers leading clinical trials and translational studies. 
  • Industry Professionals Sponsoring Clinical Trials: Stakeholders responsible for trial funding, management, and oversight. 
  • Fellows-in-Training and Junior Faculty Members: Emerging professionals seeking to deepen their expertise in CGT and BMT. 
  • Clinicians in CGT and BMT: Medical professionals involved in developing innovative cell and gene therapies for patient care. 
ACCREDITED BY:

Participants completing the course will earn 10 Hours of Continuing Education (CE) or Continuing Medical Laboratory Education (CMLE) Hours, accredited by ASCP. 

Note: To receive a certificate of course completion, participants must complete all training modules and pass the associated quizzes. 

CONTACT US

If you need help with registration or have questions, please contact us.

Contact

CELL THERAPY LEADERSHIP Micro Course PLANNING FACULTY 

Bruce Levine, PhD
Barbara and Edward Netter Professor
University of Pennsylvania
Philadelphia, PA, United States



Emily Hopewell, PhD
Assistant Professor
Director Cell and Gene Therapy Manufacturing
Indiana University
Indianapolis, IN, USA


Andrew Fesnak, MD
Assistant Professor of Clinical Pathology and Laboratory Medicine
Perelman School of Medicine
Director, Cell Manufacturing and Development, CVPF
University of Pennsylvania
Philadelphia, PA, USA


YOU MAY ALSO BE INTERESTED IN:

Cell Therapy Leadership Training Program

Format: In-person training and mentoring
Length: 5-day training

A premier ISCT scholarship initiative that integrates advanced training and mentorship from world-renowned CGT experts to develop future CGT leaders.